Emett's work with Melanoma NZ was centred around prevention. He recommended regular skin checks as well as sun protection, which was why he supported the campaign.
Blunt's Lite+ UV umbrella protects from UV light, making it handy for sunny and rainy days. The umbrellas sell for $139, from which $34.75 is donated to Melanoma NZ.
Over summer, Blunt and Melanoma NZ will pop up at outdoor events providing a free UV umbrella loan service.
Emett said attitudes about sun safety were changing as more people became aware of how harsh the New Zealand sun was.
"Dad was a farmer, but back then it was different. It was a little more carefree. There wasn't that awareness.
"It's a hell of a lot different now. I think everyone realises how harsh the sun is and how easy it is to get burned.
"The risk of getting melanoma is very high and the easiest way to prevent it is to make sure you're wearing sunscreen and hats and shirts. We definitely don't want Kiwis to not enjoy the outdoors because that's why we love New Zealand."
Emett has also thrown his support behind the the public funding of potentially lifesaving melanoma treatment drug Keytruda for New Zealand sufferers.
Pharmac declined funding at the beginning of this month.
"It's something we should look at a hell of a lot more seriously," he said.
"I know it's complex, but it seems to be working so I think it needs a better look and possibly a different approach. [Pharmac] should work towards getting it approved and work with more case studies, rather than dismissing it."
Keytruda has been found to be effective in about one-third of patients with advanced melanoma, for which there is no other treatment.
However a spokesman for the Government's medicines-funding agency, Pharmac, said its clinical committees had reviewed the evidence and recommended that Keytruda have a low priority for funding.